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Abstract
Clostridium difficile is the most commonly associated cause of antibiotic associated disease (AAD), which caused ,21,000
cases of AAD in 2011 in the U.K. alone. The golden Syrian hamster model of CDI is an acute model displaying many of the
clinical features of C. difficile disease. Using this model we characterised three clinical strains of C. difficile, all differing in
toxinotype; CD1342 (PaLoc negative), M68 (toxinotype VIII) & BI-7 (toxinotype III). The naturally occurring non-toxic strain
colonised all hamsters within 1-day post challenge (d.p.c.) with high-levels of spores being shed in the faeces of animals that
appeared well throughout the entire experiment. However, some changes including increased neutrophil influx and
unclotted red blood cells were observed at early time points despite the fact that the known C. difficile toxins (TcdA, TcdB
and CDT) are absent from the genome. In contrast, hamsters challenged with strain M68 resulted in a 45% mortality rate,
with those that survived challenge remaining highly colonised. It is currently unclear why some hamsters survive infection,
as bacterial & toxin levels and histology scores were similar to those culled at a similar time-point. Hamsters challenged with
strain BI-7 resulted in a rapid fatal infection in 100% of the hamsters approximately 26 hr post challenge. Severe caecal
pathology, including transmural neutrophil infiltrates and extensive submucosal damage correlated with high levels of toxin
measured in gut filtrates ex vivo. These data describes the infection kinetics and disease outcomes of 3 clinical C. difficile
isolates differing in toxin carriage and provides additional insights to the role of each toxin in disease progression.
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Introduction
Since its first association with antibiotic-associated disease
(AAD) in 1977, Clostridium difficile has been recognised as the most
commonly identified cause of nosocomial diarrhoea world-wide
[1]. C. difficile infection (CDI) typically occurs following antibiotic
therapy, in which disruption of the resident gut flora leaves the
intestine susceptible to C. difficile outgrowth. CDI can result in a
range of clinical sequelae; asymptomatic carriage to severe
diarrhoea, pseudomembranous colitis and death. In the U.K.
cases of CDI peaked in 2007 at 57,255 cases but, more recently
CDI rates have declined to 21,682 in 2011, presumably due to the
modification of antibiotic use and the implementation of improved
containment barrier protocols [2, www.hpa.org.uk &
www.hps.scot.nhs.uk]]. In the US, C. difficile is associated with
over 14,000 deaths annually [www.cdc.gov/HAI/organisms/cdiff
updated 2010]. The total identifiable cost of CDI was estimated to
be £4000 per case in England in 1996 [3]. On this basis such
infections conservatively cost the U.K. £87 million in 2011.
Disease has largely been associated with the production of two
large toxins, toxin A (TcdA) and toxin B (TcdB), which are
encoded by tcdA and tcdB (respectively) along with three other
genes on the pathogenicity locus (PaLoc) [4]. Variations within this
locus are recognised by a typing scheme, which recognises at
present 31 different toxinotypes [5,6]. These include the
toxinotype III group to which Ribotype 027 isolates [7] have
been associated with global CDI increase. These strains typified by
the NAP01/Ribotype 027 isolates (A+B+CDT+) were responsible
for 41.3% of all CDI cases between 2007–2008 in the U.K. [8].
Ribotype 027 isolates have been associated with increased disease
severity (such as toxic megacolon) and relapse rates [9]. Another
toxinotype that has also been associated with a global increase of
CDI outbreaks, especially in Asia, are the A2B+ toxinotypes
(types VIII, X, XVI, XVII, XXX & XXXI). In 2008 the
proportion of A2B+ isolates recovered from Korean CDI cases
was 25.7% compared to 4.2% of isolates recovered in 1995
[10,11]. After initially being thought as non-pathogenic it is now
known that A2B+ toxinotypes can cause a wide spectrum of
disease including pseudomembranous colitis and mortality
[12,13]. Toxin A2B+ isolates have typically been typed as
Ribotype 017, however, in recent years some A2B+ strains
isolated in China & Australia appear as distinctly separate
ribotypes [14,6]. Along with toxigenic strains, naturally occurring
non-toxigenic (A2B2) C. difficile are associated with asymptomatic
carriage in both adults and infants. In these strains the PaLoc
region encoding the toxins is replaced by a short sequence of
115 bp. Non-toxigenic carriage rates depend on age with several
reports highlighting infants (#2 years-old) and the elderly as
sources of community C. difficile, with carriage rates as high as
26.5% [15] and 2.7% [16], respectively.
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e64121
Sporulation, which is the transformation of vegetative cells to
metabolically dormant endospores, is an important process for C.
difficile transmission. As C. difficile spores are shed in the faeces of
CDI patients, any surface or device contaminated with faeces can
act as a reservoir for infection [17]. C. difficile spores are highly
resistant to several hospital cleaning agents [18], desiccation [19],
pH extremes and high temperatures [20]. Deakin et al., [21]
elegantly showed that sporulation is essential for a persistent and
relapsing disease and that transmission can occur through
environmental contamination, direct contact and airborne trans-
mission. C. difficile strains that exhibit increased disease severity
and relapse are typically associated with increased sporulation
rates compared to non-epidemic strains and historical strains
[22,23].
Within this study, we investigated clinical strains that naturally
express different combinations of the toxins in the golden Syrian
hamster model of disease. This model mirrors many clinical
aspects of human CDI, as hamsters pre-treated with clindamycin
results in haemorrhagic caecitis, which manifests as ‘wet tail’ and
eventually death [1,24]. In this manuscript we have used this
model to characterise the disease outcomes of three clinical C.
difficile strains; BI-7 – toxinotype III (A+B+CDT+), isolated from
an epidemic outbreak in Portland, U.S. 2003, M68 - toxinotype
VIII (A2B+CDT2), isolated during a C. difficile outbreak in
Dublin, Ireland 2004 [12] & CD1342 –PaLoc negative
(A2B2CDT2), isolated from an asymptomatic paediatric patient
in Oxford, U.K. 2009 [25].
Materials and Methods
Bacterial strains and spore preparation
C. difficile BI-7 was donated by Dr Trevor Lawley (Wellcome
Sanger Institute, Cambridge, U.K.); M68 was obtained from Dr
Richard Stabler (London School of Hygiene and Tropical
Medicine, London, U.K.) and CD1342 was obtained from Dr
Kate Dingle (Oxford University, Oxford, U.K.). BI-7 is Ribotype
027, toxinotype III (A+B+CDT+), M68 is Ribotype 017,
toxinotype VIII (A2B+CDT2) [12] and CD1342 is Ribotype
005, toxinotype PaLoc negative (A2B2CDT2) [25]. Strains were
grown on CCEY agar supplemented with cefoxitin-cycloserine,
egg emulsion (Lab M, Lancaster, U.K.) and erythromycin
(100 mg/L; M68 & CD1342) or clindamycin (20 mg/L; BI-7) at
37uC under anaerobic conditions. Animal inoculation spores were
made according to Buckley et al. [24] and were enumerated, to
calculate the inoculating dose, by 10-fold serial dilutions plated
onto supplemented CCEY agar plates as above.
Minimum inhibitory concentration (MIC)
The MIC of C. difficile BI-7, M68 and CD1342 to erythromycin
and clindamycin was determined by the broth doubling dilution
method as described by Andrews [26]. Briefly, rows of pre-
conditioned BHI broth (90 ml) were supplemented with a
concentration range of 1024–0.5 mg/ml of either antibiotic. Wells
were inoculated with ,5000 spores/100 ml (as determined from
spore preparations above) and incubated at 37uC for 48 h
anaerobically. A no antibiotic positive control row was setup
alongside an uninoculated sterility control row. After incubation,
plates were visually inspected and compared to the controls; the
MIC end point was determined as the lowest concentration of
antibiotic at which there is no visible growth. Results are given as
the median MIC from at least three assays.
Ethics statement
All procedures were strictly conducted according to the
requirements of the Animals (Scientific Procedures) Act 1986
approved by the Home Office, U.K. (project licence 60/4218).
Animal experiments
All hamster procedures, including telemetry chip insertion,
clindamycin dosing and C. difficile challenge, were done following
to Buckley et al. [24]. For survival assays, animals were monitored
for any signs of morbidity, including ‘wet tail’. Animals were culled
if core body temperature fell below 35uC (previously shown to be a
relevant and effective endpoint). C. difficile faecal shedding was
monitored in those animals that survived challenge. When an
animal succumbed to infection, to establish level of colonisation,
the caecum and colon were removed aseptically at post-mortem. To
enumerate the total bacterial load (spores and vegetative cells),
each section was opened longitudinally, and the contents were
removed by gentle washing in 10 ml PBS (luminal associated
bacteria). The tissues washed in 10 ml PBS and homogenized in
5 ml of PBS for 1 min (tissue associated bacteria), and viable
counts were determined for the homogenates. Serial 10-fold
dilutions were plated on supplemented CCEY agar plates. To
determine the numbers of spores present in the samples, the
samples were heated for 15 min at 56uC, and the numbers of
spores present were determined by the viable count method as
described above. To monitor the bacterial recoveries as the
infection progressed, at least 5 animals were each culled at 1-, 3- &
11-days post challenge (d.p.c), where the caecum and colon were
excised and processed as above. Results are shown as mean
number of recovered bacteria from 2 biological replicates, where a
total of at least 5 animals were included per time point. Colonies
were confirmed using multilocus variable-number tandem-repeat
analysis (MVLA) [27 data not shown].
Detection of in vivo toxin levels
Production of C. difficile toxins were detected in vitro using filtered
caecum content from animals taken during post mortem as described
by Buckley et al., [24]. Briefly, monolayers of Vero cells (kidney
epithelial cells) were washed with preheated sterile PBS before
addition of serial diluted filtered gut content in supplemented
EMEM and incubated for 18 h at 37uC (5% CO2). Cells were
washed with PBS, fixed in 1% formalin for 10 min then washed
again. Fixed adherent cells were stained with Geimsa for 30 min
then washed before addition of 0.1% SDS and left for 1 h. Optical
density was taken using an ELx808 Ultra microplate reader (Bio-
Tek instruments) at 600 nm and compared to non-infected
hamster caecal and colon gut contents as a negative control. If
the toxin dilution was able to cause cell toxicity (cell rounding) this
leads to the loss of cell adherence resulting in a reduced staining
and hence optical density of the wells. Results are expressed as
LOG reciprocal titre.
Histology
Caecum samples were prepared for simple histology as
described by Goulding et al, [28]. Caecal pathology was scored
in a blinded fashion, grading neutrophil margination (0, no
neutrophil accumulation; 1, local acute neutrophil accumulation;
2, extensive submucosal neutrophil accumulation; 3, transmural
neutrophilic infiltrate), haemorrhagic congestion (0, normal tissue;
1, engorged mucosal capillaries; 2, submucosal congestion with
unclotted blood; 3, transmural congestion with unclotted blood),
hyperplasia (0, no epithelial hyperplasia; 1, twofold increase in
thickness; 2, threefold increase in thickness; 3, fourfold or greater
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increase in thickness), and percent of epithelial barrier involvement
(0, no damage; 1, less than 10% of mucosal barrier involved; 2, less
than 50% of mucosal barrier involved; 3, more than 50% mucosal
barrier involved). Results are expressed as mean pathology score
per strain for each criterion.
Statistical analysis
All statistical analyses were performed using the GraphPad
Instat 3.10 (GraphPad Instat Software). A Mann-Whitney analysis
of variance analysis (ANOVA) was used to determine significant
Figure 1. Survival of hamsters challenged with C. difficile strains. (A) Survival graph of hamsters challenged with either C. difficile CD1342 (full
line), M68 (long dashed line), BI-7 (dash/dot line) or R20291 [dotted line (R20291 data from 24]. (B) Typical body temperature kinetics of a hamster
challenged with CD1342 following the usual diurnal pattern. (C) Body temperature kinetics of a surviving hamster challenged with M68, (D) a hamster
that succumbed to M68 challenge & (E) a hamster challenged with BI-7. Top bar represents when symptoms, typically ‘wet tail’, manifest. A typical
febrile response (maximum temperature of 39.3uC) was seen prior to onset of observed symptoms.
doi:10.1371/journal.pone.0064121.g001
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difference in bacterial recoveries between all time points exam-
ined. P values #0.05 were considered significant.
Results
Antimicrobial susceptibility
C. difficile M68 and CD1342 were highly resistant to both
erythromycin and clindamycin, MIC.1024 mg/ml & .256 mg/
ml, respectively. Strain BI-7 showed resistance to clindamycin
(MIC=64 mg/ml) but was highly susceptible to erythromycin
(MIC=0.125 mg/ml). Using this data we determined that a one-
day clindamycin hamster treatment model could be used without
any diminutive effects on the initial inoculum for each strain.
Telemetry monitoring and survival of infected hamsters
Challenge of clindamycin pre-treated hamsters with 10,000
spores of C. difficile BI-7, M68 or CD1342 resulted in a 100%
colonisation rate. Hamsters challenged with the toxin negative
(A2B2) strain CD1342 resulted in a 100% survival rate with no
signs of morbidity (Figure 1A & B). In contrast, when challenged
with M68 (A2B+) 55% (6/11) of hamsters survived, however all
animals showed classical symptoms of C. difficile infection, i.e. ‘wet
tail’ (Figure 1A & C). Those animals that succumbed to infection
with M68 had a mean time to cull of 82.55 h616.9 h SEM,
however a wide range between 43.7 h and 127.0 h was observed
(n = 5). An extended period of high body temperature was
associated with those hamsters that survived M68 infection, e.g.
a peak body temperature of 39.3uC was observed before the onset
of symptoms in the surviving hamster profile shown in Figure 1C.
In comparison hamsters that succumbed to M68 challenge showed
slightly elevated body temperatures before the rapid temperature
drop associated with CDI in hamsters (Figure 1D). Animals
challenged with BI-7 resulted in a 100% fatal infection with a
mean time to cull of 26.3 h60.75 h SEM. When animals
succumbed to infection a rapid temperature drop was observed
similar to other ribotype 027 isolates (Figure 1A & E; [24]).
Faecal shedding of CD1342 & M68
Shedding profiles of either CD1342 or M68 were obtained from
the faeces of animals that survived C. difficile challenge. High
numbers of CD1342 were recovered from the faeces 2-d.p.c. (c.
1.86106 CFU/g21 faeces) followed by a slow decrease with small
numbers of spores recovered at 11-d.p.c. (c. 2.26103 CFU/g21
faeces) (Figure 2). Animals challenged with M68 also peaked 2-
d.p.c. although recoveries were at least 2 LOG lower initially (c.
7.26104 CFU/g21 faeces) compared to CD1342 (Figure 2).
Colonisation kinetics non-toxic of CD1342
To assess the colonisation kinetics of C. difficile CD1342 after
inoculation, hamsters were culled at 1-, 3- & 11-d.p.c. to quantify
bacterial levels in the caecum (CAE) and colon (COL). One-day
after challenge with 104 spores/animal, total C. difficile caecum
levels reached approximately 5.76107 CFU/organ with higher
bacterial levels in the lumen (-LA) compared to those bacteria
more intimately associated with the tissue (-TA) (5.26107 &
5.06106 CFU/organ, CAE-LA & CAE-TA, respectively)
(Figure 3A). Levels recovered from the colon were similar
compared to the caecum (Figure 3A). At 1- & 3-d.p.c. the
percentage of spores present was high representing 54 (CAE-LA),
39 (CAE-TA), 83 (COL-LA) & 80% (COL-TA) of total bacteria
isolated, respectively in both tissues (Figure 3B), whilst at the
experimental end-point (11-d.p.c.) the total number of bacteria
isolated generally decreased by ,1 LOG CFU/organ across all
organ sites (Figure 3C).
Figure 2. Feacal shedding of C. difficile spores. C. difficile recovery from faeces of surviving hamsters challenged with either CD1342 (full line) or
M68 (dotted line). Bacterial faecal recoveries represent the geometric mean of 2 biological repeats, where each experiment used 3 animals per time
point, plus the standard error of the mean (SEM).
doi:10.1371/journal.pone.0064121.g002
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Colonisation kinetics of M68
To measure the colonisation kinetics of C. difficile M68 in the
caecum and colon, hamsters were culled at 1-, 3- & 11-d.p.c. and
additionally if the animals succumbed to infection. At 1-d.p.c.,
caecum levels reached approximately 7.36107 CFU/organ whilst
levels in the colon were slightly less, 8.86106 CFU/organ
(Figure 4A). Again bacterial recoveries were higher in the lumen
than those more intimately associated with the tissues. By 3-d.p.c.
the pattern of colonisation remained similar to that seen on day 1,
although the levels of spores recovered from most tissues increased
(Figure 4B). The recoverable bacterial levels of those animals that
succumbed to infection (45%; ,83 h post challenge) were high
across all tissues sites sampled, although showing no significant
difference to those animals culled at a similar time point (3-d.p.c.),
which showed no clinical symptoms (Figure 4C). At experimental
end-point (11-d.p.c.), surviving hamsters had high C. difficile levels
in all tissue sites however there was a c.a. ,1 LOG reduction
especially in the organisms more intimately associated with the
tissues (Figure 4D).
Colonisation kinetics of BI-7
Hamsters challenged with BI-7 resulted in a rapid fatal infection
after ,26 h. Total bacteria recovered at this time were
significantly lower by at least 1 LOG than either CD1342 &
M68 at the same time point (1-d.p.c.) with caecal recoveries
highest compared to colon (6.96106, 3.16105, 5.66105 &
2.56104 CFU/organ; CAE-LA, CAE-TA, COL-LA & COL-
TA, respectively; p#0.0061 for all tissues vs both CD1342 & M68)
(Figure 5). Levels of spores recovered were significantly lower
compared to those seen with CD1342 at 1-d.p.c. (p=0.0003 all
tissues) (Figure 5).
In vivo toxin levels
In vivo toxin activity was measured semi-quantitatively in vitro
using a Vero cell toxicity assay by serially diluting filtered caecal
luminal contents, and calculating the maximum fold-dilution at
which cell toxicity was still detected (cell rounding). At each time
point tested, little cell rounding activity was detected in the caecal
filtrate from animals challenged with CD1342 (Figure 6A).
Challenge with M68 resulted in a wide spread of caecal toxin
measurements with peak toxin detected at 3-d.p.c. (Figure 6A).
Hamsters that succumbed to infection with M68, ,3-d.p.c., were
associated with increased caecal toxin levels however these data
were not significantly different compared to those hamsters which
were culled at day 3 (p=0.0568) (Figure 6B). The difficulty with
this data is it is not possible to differentiate between those animals
culled at 3-d.p.c. that may have subsequently succumbed to
infection compared to those that would have survived. In
comparison to animals that succumbed to challenge with M68,
animals infected with BI-7 and culled at ,26 h showed
significantly higher levels of toxin activity (,LOG 3.8 vs 5.4;
p=0.0215) (Figure 6B).
Histological changes
Considering the lack of clinical symptoms, histological analysis
of the caeca from hamsters challenged with CD1342 and sacrificed
1-d.p.c. showed surprising changes; whilst the epithelial layer
Figure 3. Colonisation kinetics of C. difficile CD1342 in
hamsters. To monitor colonisation throughout the infection process
hamsters were culled at 1- (A), 3- (B) and 11 (C) days post challenge. C.
difficile was recovered from the caecum (CAE) and the colon (COL)
either associated with the lumen (LA) or the tissue (TA). Filled bars
represent vegetative bacteria whilst empty bars indicate bacteria in
spore form. Bacterial recoveries represent the geometric mean plus the
standard error of the mean (SEM) of 2 biological replicates, where a
total of at least 5 animals were used per time interval.
doi:10.1371/journal.pone.0064121.g003
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seemed intact unclotted red blood cells were associated within the
villus structure (Figure 7A & C). Accompanying this haemorrhagic
congestion was an increase in circulating submucosal neutrophil
cells. Similar caecal pathology was also observed in all hamsters
infected with CD1342 and culled at 3-d.p.c. By 11-d.p.c. hamsters
challenged with CD1342 showed no caecal pathology, tissue was
similar to uninfected hamsters (Figure 7). Similarly, animals
challenged with M68 and culled 24 h later showed a modest
increase in circulating neutrophils and increased numbers of red
blood cells within the capillaries. Whilst animals culled at 3-d.p.c.
showed typical characteristic pathology exemplified by high
epithelial cell loss, transmural neutrophil infiltrate and high levels
of unclotted red blood cells associated with the villus structure and
the lumen (Figure 7A & D). Intestinal pathology was most
pronounced at 3-d.p.c. but intestinal epithelial cell loss and
inflammatory cell infiltration persisted until experimental end-
point (11-d.p.c.) (Figure 7). In addition, these animals showed
tissue hyperplasia in the terminal colon that persisted to day 11
(data not shown). Hamsters that succumbed to infection with M68,
showed more caecal pathology in comparison to those lacking
Figure 4. Colonisation kinetics of C. difficileM68 in hamsters. To monitor colonisation throughout the infection process hamsters were culled
at 1- (A), 3- (B) and 11 (D) days post challenge and if animals succumbed to infection (C). C. difficile was recovered from the caecum (CAE) and the
colon (COL) either associated with the lumen (LA) or the tissue (TA). Filled bars represent vegetative bacteria whilst empty bars indicate bacteria in
spore form. Bacterial recoveries represent the geometric mean plus the standard error of the mean (SEM) of 2 biological replicates, where a total of at
least 5 animals were used per time interval.
doi:10.1371/journal.pone.0064121.g004
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symptoms and culled at 3-d.p.c. Typically more unclotted red
blood cells was associated with the tissue and severe epithelial cell
loss was apparent (Figure 7B). At clinical end-point, caecal tissue
from hamsters challenged with BI-7 showed pathological changes
typically associated with C. difficile infection (Figure 7B & E).
Caecal tissue showed high levels of transmural neutrophil infiltrate
and unclotted red blood cells with wide-ranging epithelial cell loss
and extensive damage to the villus structure.
Discussion
Here we present a detailed virulence study of three human
isolates of C. difficile, BI-7, M68 and CD1342, in the hamster
model of infection. Antimicrobial susceptibility assays showed both
M68 and CD1342 had high-level resistance to clindamycin
(.256 mg/ml), whilst BI-7 had an intermediate level of resistance
(64 mg/ml). Clindamycin is an important clinical antibiotic that
has been implicated with induction of CDI [29] with many strains
Figure 5. Colonisation kinetics of C. difficile BI-7 in hamsters. Bacteria recovered from hamsters challenged with BI-7 at time of cull (,26 h). C.
difficile was recovered from the caecum (CAE) and the colon (COL) either associated with the lumen (LA) or the tissue (TA). Filled bars represent
vegetative bacteria whilst empty bars indicate bacteria in spore form. Bacterial recoveries represent the geometric mean plus the standard error of
the mean (SEM), where a total of at least 5 animals were used.
doi:10.1371/journal.pone.0064121.g005
Figure 6. Cytotoxicity of caecal contents from hamsters challenged with C. difficile strains. C. difficile CD1342 (open circles), M68 (closed
squares) or BI-7 (closed triangles) at either 1-, 3- & 11-d.p.c (A) or if the hamsters succumbed to infection (B). Toxin was quantified using a cell-based
assay by serially diluting filtered caecal content obtained at post-mortem. Symbols represent mean toxin levels.
doi:10.1371/journal.pone.0064121.g006
Infection of Hamsters with C. difficile
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Figure 7. Mean histology scores from hamsters challenged with C. difficile strains. C. difficile CD1342 (filled columns), M68 (open columns)
or BI-7 (checked column) at either 1-, 3- & 11-d.p.c (A) or if the hamsters succumbed to infection (B). Caecal pathology was graded by neutrophil
margination, haemorrhagic congestion, hyperplasia and percent barrier involvement from at least four animals. Typical caecal histology from
hamsters challenged with either CD1342 (at 1-d.p.c. - C), M68 (at 3-d.p.c. - D) or BI-7 (at ,26 h - E). Red arrows denotes unclotted red blood cells
within the villus structure; black arrows denotes epithelial barrier destruction & green arrows denotes transmural neutrophil infiltrate.
doi:10.1371/journal.pone.0064121.g007
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showing high resistance including all A2B+ strains isolated from
South Korean CDI cases [30]. Previously, we described the
infection kinetics of a clindamycin-sensitive Ribotype 027 U.K.
isolate, R20291 (clindamycin MIC=8 mg/ml), where 100% of
hamsters succumbed to infection with a mean time of 46.7 h [24].
The much faster infection kinetics displayed by the closely related
Ribotype 027, BI-7, probably reflects the more efficient germina-
tion and subsequent survival of this strain within the clindamycin
treated environment of the hamster gut. Due to this high-level
clindamycin resistance hamsters were challenged with C. difficile
one-day prior to clindamycin infection without any detrimental
effects on inocula.
Challenge of hamsters with C. difficile strain CD1342 resulted in
a 100% colonisation rate, with animals remaining colonised until
the end of the study 14-d.p.c. This is similar to other studies with
non-toxigenic strains where colonisation was observed until at least
31-d.p.c. [31]. Although PCR detection for the presence of the
PaLoc and for the CDT-encoding genes in CD1342 were negative
(data not shown), this strain still caused mild caecal pathology
characterised by local acute epithelial cell loss, haemorrhagic
congestion and neutrophil cell influx. This suggests that, at least in
this strain, C. difficile CD1342 possesses an as yet uncharacterised
virulence factor that is able to cause cell loss and damage,
activating the immune system in the process. In the absence of the
dominating effects of the toxins, i.e. using naturally occurring non-
toxic strains, the hamster model of infection is ideally suited to
elucidating potential transmission and/or colonisation factors for
C. difficile infection. Sequencing of these types of non-toxic strains
may give us more insight to such factors [32].
Bacterial germination and outgrowth of CD1342 was rapid
within the animal as even assuming 100% germination from the
104 spores used to challenge the animals bacteria in the caecum
and colon had multiplied by at least,3 LOG CFU within the first
24 h. High levels of spores were also observed, demonstrating the
rapid in vivo germination, replication, sporulation and shedding of
this strain in this short timeperiod. The rapid growth and high
rates of shedding, thus enhanced transmission potential, coupled
with potential acquisition of virulence factors could result in new
clades of C. difficile with enhanced virulence similar to that
observed with ribotype 027 strains, resulting in new global
epidemics. The intestinal environment is a ‘hotbed’ for genetic
exchange mediated by bacteriophages [33] and these exchanges
have resulted in the acquisition of virulence factors like antibiotic
resistance determinants and pathogenicity islands in several
bacterial species, such as the LEE locus in enterohemorrhagic E.
coli [34]. This type of genetic transfer has potential implications for
the introduction of toxin encoding determinants, such as the
PaLoc, to be transferred to previously non-toxic strains. This has
potential implications on the potential use of non-toxic strains as
probiotics to toxic C. difficile [31,35]
When challenged with the toxin A negative C. difficile strain,
M68, 100% of hamsters were colonised and shed this strain, with
45% of hamsters succumbing to disease. As all hamsters showed
classic symptoms of CDI (wet tail) before potential recovery, the
use of the telemetry system proved invaluable as we were able to
discriminate those animals that had transitory disease from those
that rapidly succumbed. These data show that, similar to a clinical
setting, strain M68 (only producing a functional TcdB) is not only
able to cause disease but can cause lethality in an in vivo model,
which suggests that TcdA is not essential for disease initiation.
However, with only a 55% survival rate in hamsters challenged
with this strain, there may be a role for TcdA in fulminant CDI
with this strain. Whilst it is not possible to directly attribute the role
of individual genes in this type of study, the use of isogenic mutants
to clarify the role of specific toxins has also been subject to
controversy. In particular there has been confusion over the role of
TcdA in CDI with isogenic mutants of C. difficile strain 630 where
toxin genes have individually been disrupted generating conflicting
data. Lyras et al. [36] first reported a minimal role for TcdA whilst
Kuehne et al. [37] found an essential role for TcdA in CDI in the
hamster. These differences may reflect the technologies used in
mutant generation, differences in SNP profiles between the strains
from different labs and even the method used to determine
endpoint of experiments using the animal model. In contrast, our
data is similar to that reported by [38], where hamsters colonised
with an A2B+ clinical isolate (CF2) had a 50% survival rate. This
suggests the role for TcdA in pathogenesis may vary dependent on
strain and experimental conditions. Differences may reflect the
acceptable endpoints criteria in different countries. However,
within this experiment in which the endpoint is more refined a
mixed picture is observed. Why some animals succumb to
infection with M68 is unclear at present. Those animals that
succumbed to infection showed no significant differences in total
bacterial organ recoveries compared to animals culled at a similar
time (3-d.p.c.). The small increase in vegetative cells observed
could produce more TcdB, as shown by the toxin assay, causing
more epithelial damage compared to those animals that survive.
Interestingly those animals that survived challenge with M68,
typically displayed an elevated core temperature above the normal
range. Macrophages exposed to either TcdA or TcdB have been
shown to release interleukin 1b (IL-1b) [39], a key cytokine that,
along with IL-6, can cause an increase in body temperature in
rodents [40]. Patients with severe C. difficile colitis often display
clinically elevated IL-1b in their stool samples [41]. Such an
increased cytokine profile could be responsible for the febrile
response seen in surviving animals. This possibility questions
whether the surviving hamsters were better able to mount an
appropriate immune response to toxin exposure, maybe due to
genetic differences as the hamsters used in this study are from an
out-bred colony.
Since the initial Canadian outbreak [42], Ribotype 027 isolates
have spread globally, causing major outbreaks in almost every
continent. These strains have been associated with increased
disease severity & reoccurrence rates, leading to this group of
strains to be classed as ‘hypervirulent’ [43,9]. When challenged
with BI-7 100% of hamsters rapidly succumbed to disease, ,26 h
post challenge. In a similar study, Razaq et al. [44] observed
increased mortality rates with epidemic Ribotype 027 isolates,
especially with a clindamycin resistant isolate. Histological analysis
of hamsters challenged with BI-7 showed severe epithelial cell loss,
transmural neutrophil infiltrate and extensive damage to the
submucosal structure. Such damage is, at least in part, due to the
high toxin titres seen from the tissue samples, which considering
the modest level of recovered bacteria is surprising. This high toxin
titre could be due to more toxin being produced or the produced
toxin is a more efficient enzyme due to changes in the protein
sequence [45]. Recently Lanis et al. [46] showed that TcdB from
strain R20291 (Ribotype 027) was more toxic due to conforma-
tional changes that occurred at a higher pH when compared to
TcdB from strain 630. Another explanation for this rapid
mortality could be the presence of the binary toxin, CDT.
Through the induction of microtubule-based protrusions, CDT
may enhance the adherence of C. difficile to host cells [47].
In conclusion, using the hamster model of infection we
characterised the infectivity profiles of three C. difficile isolates
varying in toxin carriage. The toxin negative strain colonised
hamsters and was shed with high efficiency but caused tissue
damage, however no clinical symptoms were observed during the
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infection process. Whereas the toxin A negative strain caused
mortality in 55% of hamsters, potentially associated with the
increased toxin detected. Those animals that survived challenge
displayed a febrile response highlighting potential host genetic
differences involved in survival of CDI. Challenge with C. difficile
BI-7 resulted in a rapid fatal infection in 100% of the animals,
causing extensive tissue damage and high toxin titres observed.
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